D
TriSalus Life Sciences, Inc. TLSI
$5.10 $0.173.45% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 20.12% -2.64% -323.64% 44.92% 67.20%
Total Depreciation and Amortization -4.07% -10.88% 14.20% -12.89% 10.86%
Total Amortization of Deferred Charges 9.36% 32.02% 6.59% -37.45% --
Total Other Non-Cash Items -50.03% 8.62% 163.13% -77.99% -219.80%
Change in Net Operating Assets -186.80% 242.40% 114.81% 50.58% -1,220.91%
Cash from Operations -62.70% 21.17% 47.39% 19.18% -23.51%
Capital Expenditure 112.33% -1,408.00% 70.41% -181.67% 9.09%
Sale of Property, Plant, and Equipment -100.00% -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 113.03% -1,328.00% 70.41% -181.67% 9.09%
Total Debt Issued -100.00% -- -- -100.00% --
Total Debt Repaid 98.59% -273.68% 13.64% -4.76% 4.55%
Issuance of Common Stock 7,881.00% -90.74% -48.45% 62.05% 14.58%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -197.88% -- -- 100.00% --
Cash from Financing 113.84% 223.58% -48.58% -77.60% 731.51%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 201.45% 261.96% 46.79% -141.51% 260.25%